Patient-Derived Xenograft and Cell Line Models of Human Primary Cutaneous Diffuse Large B-Cell Lymphoma-Leg Type

Affiliations

• ¹ BRIC (BoRdeaux Institute of onCology), INSERM UMR1312, Team 5, University of Bordeaux, Bordeaux, France.
• ² BRIC (BoRdeaux Institute of onCology), INSERM UMR1312, Team 5, University of Bordeaux, Bordeaux, France; Tumor Bank and Tumor Biology Laboratory, University Hospital of Bordeaux, Bordeaux, France.
• ³ BRIC (BoRdeaux Institute of onCology), INSERM UMR1312, Team 11, University of Bordeaux, Bordeaux, France.
• ⁴ Tumor Bank and Tumor Biology Laboratory, University Hospital of Bordeaux, Bordeaux, France.
• ⁵ Dermatology Department, University Hospital of Bordeaux, Bordeaux, France.
• ⁶ BRIC (BoRdeaux Institute of onCology), INSERM UMR1312, Team 5, University of Bordeaux, Bordeaux, France; Pathology Department, University Hospital of Bordeaux, Bordeaux, France.
• ⁷ BRIC (BoRdeaux Institute of onCology), INSERM UMR1312, Team 5, University of Bordeaux, Bordeaux, France; Dermatology Department, University Hospital of Bordeaux, Bordeaux, France.
• ⁸ BRIC (BoRdeaux Institute of onCology), INSERM UMR1312, Team 5, University of Bordeaux, Bordeaux, France; BRIC (BoRdeaux Institute of onCology), INSERM UMR1312, Team 5, CNRS, Université de Bordeaux, Bordeaux, France. Electronic address: Laurence.bresson-bepoldin@inserm.fr.